Objective:To investigate the efficacy and prognosis of venetoclax combined with hypomethylating agents(HMAs)in the treatment of relapsed/refractory acute myeloid leukemia(AML).Methods:From June 2021 to February 2022,1...
supported by the Key Project of Novel Coronavirus Normalized Prevention and Control in Hubei Province(2021ACB003);the National Science and Technology Major Projects(2020ZX10001016);the Natural Science Foundation of Fujian Province(2020J02004)。
The COVID-19 pandemic is a global health crisis.Moreover,emerging mutated virus strains present an even greater challenge for existing vaccines and medications.One possible solution is to design drugs based on the pro...
Objective: to analyze the efficacy of azacytidine combined with chemotherapy in the treatment of elderly acute myeloid leukemia. Methods: the time of case determination was from January 2018 to January 2021, and the c...
Resistance to the chemotherapeutic drug 5'-azacytidine(5'-AZA)is a major obstacle in the treatment of patients with acute myeloid leukemia(AML).The uridine-cytidine kinase 1(UCK1)has an established role in activating ...
Objective: to explore the clinical treatment of critically ill MDS and elderly patients with acute myeloid leukemia in the formulation of treatment plan, azacytidine, low-dose cytarabine combined intervention measures...